EFNB2 and glioblastoma: We have recently reported the implications of DLL4‐Notch and EphrinB2‐EphB4 signalling in human hyper‐vascularized brain tumours including glioblastoma (GBM) 17, hemangiopericytoma 18 and hemangioblastoma 19.